Inviragen's Hand, Foot and Mouth Disease vaccine generates immune responses in 100% of study participants
13-Mar-2012 -
Inviragen reported top-line results of a placebo-controlled, randomized Phase 1 trial of INV21, the Company’s highly purified virus particle vaccine against Hand, Foot and Mouth Disease (HFMD) caused by enterovirus 71 (EV71).
In the clinical study, healthy adults received two immunizations each ...
Hand, Foot and Mouth Disease
phase I studies